mutat
ultim
sourc
genet
variat
mutat
rate
signific
impact
evolutionari
rate
intraspecif
variabl
mutat
rate
mani
virus
bacteria
indic
mutat
rate
optim
natur
select
given
mutat
deleteri
burden
excess
mutat
load
select
strain
abnorm
high
mutat
rate
principl
led
sturtev
ask
mutat
rate
evolv
zero
larg
bodi
theoret
experiment
work
suggest
select
pressur
higher
mutat
rate
due
either
physicochem
cost
maintain
lower
one
select
advantag
increas
suppli
benefici
mutat
mani
argu
adapt
benefit
high
mutat
rate
pathogen
microb
often
exist
dynam
environ
subject
host
immun
pressur
howev
direct
select
variant
higher
mutat
rate
occur
advantag
past
mani
case
difficult
separ
caus
higher
mutat
rate
consequ
rna
virus
ideal
system
studi
select
forc
act
mutat
rate
interspeci
mutat
rate
rang
error
per
nucleotid
copi
studi
antimut
hypermut
suggest
fidel
vari
severalfold
within
speci
sever
burden
mutat
load
exert
strong
downward
pressur
mutat
rate
hypermut
strain
attenu
vivo
given
short
gener
time
remark
fecund
mani
rna
virus
small
kinet
cost
higher
fidel
result
strong
select
antimut
howev
observ
attenu
antimut
rna
virus
vivo
led
mani
argu
adapt
benefit
high
mutat
rate
genet
divers
provid
rich
substrat
viru
evolut
face
vari
intrahost
environ
concept
central
viral
quasispeci
theori
gener
propos
link
genet
divers
viral
fit
defin
select
forc
shape
viral
mutat
rate
studi
antimut
variant
mutant
polioviru
select
serial
passag
ribavirin
rna
viru
mutagen
rnadepend
rna
polymeras
rdrp
variant
contain
singl
glycin
serin
substitut
basal
mutat
rate
report
approxim
wildtyp
wt
viru
mutant
attenu
polioviru
receptor
pvr
transgen
mice
rel
import
replic
speed
fidel
phenotyp
clear
biochem
assay
suggest
physicochem
cost
high
fidel
system
contribut
overal
fit
remain
unquantifi
measur
rel
fit
direct
competit
serial
passag
quantit
revers
transcript
polymeras
chain
reaction
qrtpcr
fig
fit
n
replic
rel
wt
moder
fit
defect
fall
percentil
dataset
fit
valu
obtain
point
mutant
polioviru
similar
condit
eg
human
epitheli
cell
hela
multipl
infect
moi
infect
cycl
passag
fig
also
measur
rel
growth
properti
wt
use
plaques
assay
measur
growth
burst
size
spread
individu
virus
absenc
competit
distribut
clonal
plaqu
size
significantli
differ
p
unpair
test
welch
correct
n
wt
n
plaqu
consist
moder
fit
defect
fig
contrast
prior
work
abl
detect
signific
replic
defect
onestep
growth
curv
rigor
synchron
frequent
time
point
larger
number
replic
fig
replic
defect
specif
hela
observ
similar
lag
cell
line
deriv
mous
embryon
fibroblast
mef
pvr
mice
fig
data
demonstr
fit
defect
larg
attribut
slower
replic
kinet
consist
biochem
assay
purifi
rdrp
reduc
mutat
rate
replic
fit
suggest
tradeoff
speed
fidel
rna
viru
replic
fit
gain
increas
replic
speed
offset
reduct
fit
due
increas
mutat
load
deriv
quantit
model
tradeoff
see
text
model
measur
replic
fit
fig
mutat
rate
fig
tabl
wt
exposur
exogen
mutagen
ribavirin
wt
equal
fit
approxim
ribavirin
base
data
model
indic
wt
incur
fit
cost
mutat
load
alon
therefor
fit
benefit
high
baselin
mutat
rate
wt
would
presum
need
offset
cost
cost
mutat
load
reduc
viral
rdrp
constrain
tradeoff
select
increas
replic
speed
rselect
increas
mutat
rate
subject
point
mutant
rselect
serial
passag
infect
cell
low
multipl
harvest
progeni
hour
midexponenti
phase
replic
point
mutant
revert
wt
within
passag
independ
lineag
fig
observ
partial
revers
passag
subset
control
lineag
viru
popul
underw
twice
mani
cellular
infect
cycl
per
passag
experienc
reduc
rselect
next
ask
whether
rselect
would
lead
genet
compens
fidel
phenotyp
posit
codon
mutat
minim
revers
passag
rselect
identifi
fix
polymorph
singlenucleotid
variant
snv
nextgener
sequenc
rselect
control
passag
popul
wt
fig
unbias
hierarch
cluster
snv
type
frequenc
indic
virus
explor
distinct
mutat
pathway
adapt
either
rselect
control
passag
regim
within
rselect
group
wt
lineag
cluster
togeth
note
larger
number
snv
within
code
region
rdrp
across
popul
found
number
distinct
snv
increas
viral
fit
introduc
ancestr
wt
backbon
exampl
fit
presenc
rselect
control
lineag
suggest
mediat
adapt
hela
cell
see
si
data
contrast
mutat
viral
helicas
found
rselect
fit
wt
si
data
like
gener
effect
replic
speed
identifi
compensatori
mutat
focus
subsequ
analysi
nonsynonym
mutat
rdrp
found
predominantli
rselect
popul
share
among
multipl
lineag
frequent
wt
two
criteria
frequenc
passag
suggest
mutat
may
arisen
first
mutat
found
rselect
wt
lineag
chang
either
fit
mutat
rate
appreci
background
fig
rselect
substitut
found
lineag
wt
popul
decreas
overal
fit
wt
p
versu
wt
test
p
versu
test
detect
effect
mutat
rate
either
background
tripl
mutant
signific
increas
fit
p
versu
test
mutat
rate
snr
p
versu
test
compar
doubl
mutant
therefor
direct
select
replic
speed
led
indirect
select
mutat
togeth
increas
polioviru
mutat
rate
sign
epistasi
among
rdrp
gain
mechanist
insight
interact
among
mutat
analyz
kinet
singlenucleotid
incorpor
misincorpor
purifi
rdrp
rdrp
exhibit
assembl
defect
rel
incub
purifi
primer
templat
atp
fig
mutat
partial
compens
assembl
defect
background
result
increas
incorpor
correct
nucleotid
opposit
u
interact
depend
reduc
rdrp
activ
background
polioviru
mutat
exhibit
alter
kinet
nucleotid
misincorpor
g
opposit
u
kinet
similar
fig
examin
relationship
rdrp
speed
fidel
use
second
polioviru
antimut
rdrp
slower
polymer
kinet
higher
fidel
rel
wt
rdrp
similar
characterist
separ
experi
infect
hela
cell
viru
recov
mutant
passag
observ
missens
mutat
gene
amino
acid
chang
identifi
togeth
experi
chang
identifi
alon
second
introduc
amino
acid
substitut
alon
combin
rdrp
case
observ
increas
elong
rate
kpol
viral
polymeras
surrog
speed
well
nucleotid
misincorpor
rate
kob
misincorpor
mutant
rel
wt
vitro
tabl
adapt
wt
highfidel
virus
gener
compar
use
assay
measur
acquisit
drug
resist
revers
attenu
point
mutat
escap
microrna
limit
number
replic
cycl
experi
mutat
come
littl
cost
assay
essenti
quantifi
benefici
mutat
rate
captur
better
impact
deleteri
benefici
mutat
adapt
measur
fit
gain
wt
passag
hela
wt
strain
cultureadapt
found
far
fit
peak
wt
increas
fit
approxim
cellular
infect
cycl
passag
fig
fig
differ
rate
fit
gain
wt
lineag
small
statist
signific
per
passag
wt
mix
linear
effect
model
p
examin
adapt
complet
distinct
environ
repeat
experi
cell
line
altern
speci
cell
type
actual
observ
greater
fit
gain
highfidel
variant
rel
wt
per
passag
mix
linear
effect
model
p
larger
fit
gain
cell
may
reflect
larger
suppli
benefici
compensatori
mutat
given
lower
baselin
fit
cell
data
suggest
despit
reduct
mutat
rate
mutat
limit
absenc
strong
select
adapt
benefit
higher
mutat
rate
counter
fit
cost
increas
mutat
load
see
fig
associ
model
next
compar
phenotyp
wt
virus
vivo
abil
gener
genet
divers
may
allow
viru
escap
host
immun
restrict
replic
better
rang
environ
avail
data
suggest
attenu
highfidel
variant
experiment
model
attribut
differ
genet
divers
infect
popul
earlier
work
viral
divers
inoculum
manipul
use
exogen
passag
ribavirin
follow
propag
absenc
mutagen
addit
passag
divers
mutant
spectrum
assess
sanger
sequenc
noncod
capsidcod
region
virus
plaqu
given
difficulti
control
type
level
genet
divers
popul
correl
studi
instead
gener
independ
stock
wt
compar
divers
nextgener
sequenc
use
intern
benchmark
analysi
pipelin
dramat
reduc
fals
posit
variant
call
see
method
identifi
variant
greater
frequenc
therefor
exclud
signific
differ
stand
genet
divers
wt
popul
even
extrem
high
moi
variant
present
unlik
complement
cooper
reproduc
cellular
context
vivo
absenc
mutat
divers
replic
wt
stock
import
polioviru
popul
subject
stringent
bottleneck
event
restrict
intrahost
divers
work
barcod
rna
virus
suggest
serial
bottleneck
infect
popul
termin
popul
colon
central
nervou
system
cn
quit
stringent
use
publish
data
quantifi
aggreg
bottleneck
size
encount
polioviru
transgen
mice
maximum
likelihood
optim
simpl
probabilist
model
estim
aggreg
bottleneck
size
inoculum
cn
fig
text
model
therefor
popul
caus
eventu
diseas
mice
deriv
virus
infect
popul
set
tight
bottleneck
mani
mutat
increas
frequenc
due
genet
drift
oppos
posit
select
infect
group
pvr
mice
intramuscularli
wt
popul
virus
abl
access
cn
effici
rout
rang
dose
fig
tabl
clear
delay
group
p
p
p
pfu
inocula
respect
lag
persist
even
infect
dose
higher
median
lethal
dose
tabl
differ
attenu
compar
prior
work
appear
due
mous
model
use
studi
cpvr
mice
report
result
similar
present
virus
spread
cn
replic
high
titer
intraven
inocul
although
wt
titer
brain
spinal
cord
margin
higher
day
post
infect
fig
p
brain
p
spinal
cord
mann
whitney
u
test
character
mutat
present
cn
popul
spinal
cord
intraven
infect
mice
fig
wt
mutat
rare
none
share
among
mice
excess
synonym
noncod
variant
rel
nonsynonym
one
data
consist
random
sampl
infect
popul
oppos
posit
select
also
examin
impact
rselect
mutat
virul
mutat
confer
fit
background
appear
affect
fidel
fig
restor
virul
nearli
wt
level
p
log
rank
test
compar
fig
contrast
tripl
mutant
replic
wt
mutat
rate
margin
increas
fit
slightli
virul
highfidel
variant
p
log
rank
test
compar
fig
therefor
restor
replic
speed
restor
virul
compens
fidel
phenotyp
use
wellstudi
antimut
variant
polioviru
identifi
select
forc
optim
pathogen
mutat
rate
use
differ
assay
identifi
signific
fit
cost
higher
fidel
directli
link
cost
viral
replic
kinet
quantit
model
tradeoff
suggest
select
replic
speed
push
viral
mutat
rate
level
impos
signific
fit
cost
baselin
due
lethal
highli
deleteri
mutat
consist
tradeoff
model
direct
select
increas
replic
speed
led
indirect
select
polymeras
higher
mutat
rate
genet
interact
quit
strong
compensatori
mutat
exhibit
reciproc
sign
epistasi
tradeoff
polioviru
rdrp
appear
generaliz
phenomenon
compensatori
mutat
increas
replic
speed
antimut
also
increas
mutat
rate
tabl
given
structur
similar
among
viral
rdrp
polymeras
rna
virus
like
subject
tradeoff
predict
molecular
mechan
govern
polymeras
kinet
mutat
rate
similar
tradeoff
essenti
constraint
forc
one
paramet
chang
anoth
case
viral
mutat
rate
chang
replic
speed
similar
tradeoff
central
kinet
proofread
hypothesi
posit
close
relationship
error
rate
biosynthet
process
kinet
compon
reaction
studi
dna
replic
protein
translat
suggest
system
optim
speed
accuraci
long
error
rate
within
toler
rang
find
similar
phenomenon
viral
rdrp
wt
gener
extraordinari
amount
mutat
load
larg
benefit
replic
speed
failur
consid
evolutionari
tradeoff
lead
teleolog
error
consequ
process
eg
increas
genet
divers
misinterpret
caus
eg
direct
select
higher
mutat
rate
similarli
find
propos
link
withinhost
genet
divers
virul
confound
fact
faster
replic
virus
virul
higher
mutat
rate
high
mutat
rate
rna
virus
highli
deleteri
fit
effect
mutat
ensur
genet
divers
extrem
rare
unlik
consist
maintain
face
intrahost
interhost
bottleneck
disput
viru
popul
harbor
minor
variant
subset
mutat
may
adapt
benefici
viru
may
virul
determin
howev
observ
genet
divers
evid
select
optim
mutat
rate
futur
benefit
novel
mutat
inde
data
show
littl
adapt
benefit
margin
increas
mutat
rate
identifi
plausibl
mechan
wherebi
observ
increas
rare
genet
divers
influenc
pathogenesi
suspect
rna
virus
subject
tradeoff
evolutionari
signific
perhap
polymeras
speed
recombin
rate
recombin
rate
polymeras
fidel
import
defin
select
forc
play
therebi
separ
caus
consequ
univers
michigan
institut
anim
care
use
committe
review
approv
protocol
mous
studi
describ
manuscript
protocol
id
univers
anim
welfar
assur
number
file
nih
offic
laboratori
anim
welfar
olaw
inform
human
endpoint
use
length
experi
number
anim
use
subsequ
euthan
tabl
frequenc
monitor
anim
welfar
consider
describ
infect
transgen
mice
section
low
passag
stock
hela
cell
week
cultur
previous
obtain
directli
atcc
kindli
provid
mari
riordan
univers
michigan
except
note
cell
use
experi
studi
maintain
minim
essenti
media
mem
invitrogen
supplement
fetal
bovin
serum
gibco
hyclon
penicillinstreptomycin
invitrogen
sodium
pyruv
invitrogen
mem
alpha
nonessenti
amino
acid
invitrogen
glutamin
invitrogen
second
stock
hela
unknown
passag
histori
obtain
michael
imperial
univers
michigan
cell
use
plaqu
assay
titer
stock
maintain
dulbecco
modifi
eagl
media
dmem
invitrogen
supplement
fetal
bovin
serum
penicillinstreptomycin
cell
describ
maintain
dmem
supplement
fetal
bovin
serum
penicillinstreptomycin
glutamin
case
cell
line
maintain
passag
time
wt
polioviru
mutant
gener
plasmid
pewm
mahoney
clone
origin
obtain
eckard
wimmer
sunystonybrook
pvr
mice
obtain
koik
tokyo
japan
via
juli
pfeiffer
ut
southwestern
maintain
specif
pathogenfre
condit
primari
mef
deriv
pvr
mice
day
embryo
harvest
wash
phosphatebuff
salin
pb
head
viscera
remov
bodi
minc
steril
razor
blade
trypsin
homogen
pipet
ml
serolog
pipett
cell
plate
dmem
supplement
fetal
bovin
serum
penicillinstreptomycin
glutamin
immort
cell
line
deriv
pvr
mef
follow
protocol
briefli
freshli
thaw
mef
plate
flask
densiti
cell
per
flask
complet
dmem
everi
third
day
cell
flask
trypsin
count
transfer
fresh
flask
densiti
cell
per
flask
cellular
popul
began
increas
passag
cell
expand
larger
vessel
ultim
frozen
passag
mutat
introduc
either
pewm
subclon
use
overlap
extens
pcr
presenc
desir
mutat
absenc
addit
mutat
verifi
sanger
sequenc
amplifi
insert
case
entir
genom
viral
rna
gener
vitro
transcript
correspond
plasmid
clone
use
rna
polymeras
viru
recov
follow
rna
transfect
hela
transfect
hela
plate
per
well
plate
day
prior
one
microgram
rna
mix
transit
mrna
transfect
reagent
miru
optimem
invitrogen
incub
accord
manufactur
protocol
appli
cell
passag
viru
harvest
cpe
within
hour
passag
stock
gener
passag
passag
viru
fresh
cell
titer
either
plaqu
assay
passag
stock
gener
passag
moi
stock
cell
subject
cycl
supernat
clarifi
centrifug
g
minut
supernat
store
aliquot
limit
number
subsequ
cycl
competit
assay
perform
essenti
describ
experi
fig
hela
cell
plate
plate
densiti
per
well
day
prior
infect
cell
infect
total
moi
equal
wt
three
replic
well
infect
pair
virus
hour
occasion
rock
hour
inoculum
remov
ml
fresh
media
appli
passag
viru
harvest
addit
hour
hour
sinc
infect
titer
passag
viru
use
calcul
dilut
factor
necessari
maintain
moi
subsequ
passag
rna
harvest
passag
use
trizol
ambion
random
hexam
use
prime
cdna
synthesi
rna
cdna
analyz
qrtpcr
use
differ
primer
andor
probe
set
duplic
pcr
reaction
sampl
primer
set
first
catggcagccccggaacagg
tgtgatggatccgggggtagcg
use
quantifi
total
viral
genom
rna
sybr
green
reaction
power
sybr
green
pcr
master
mix
thermo
two
custom
taqman
probe
appli
biosystem
use
quantifi
number
wt
genom
duplic
well
averag
rel
amount
wt
rna
determin
normal
cycl
threshold
probe
com
primer
set
ctviru
ctcom
normal
valu
viru
passag
compar
passag
obtain
ratio
rel
rel
ct
valu
convert
reflect
fold
chang
ratio
chang
ratio
mutant
rel
chang
ratio
wt
function
passag
fit
ratiomut
ratiowt
time
competit
assay
ribavirin
fig
perform
exact
manner
except
serumfre
media
use
drug
mock
passag
competit
assay
fig
compar
experiment
viru
eg
wt
etc
tag
wt
refer
plate
cell
per
well
either
hela
plate
infect
perform
moi
complet
media
hour
hour
media
aspir
fresh
ml
growth
media
appli
passag
hour
dilut
factor
passag
requir
maintain
moi
hela
competit
competit
rna
harvest
competit
perform
plate
use
purelink
pro
viral
rnadna
kit
invitrogen
cdna
synthesi
perform
addit
com
primer
set
see
use
primer
pair
seqtag
ttcagcgtcaggttgttga
rev
wt
seqtag
cagtgtttgggagagcgtct
wt
seqtag
agcgtgcgcttgttgcga
rev
wt
seqtag
cagtgtttgggagagcgtct
quantifi
refer
test
sampl
respect
note
also
competit
regress
fit
passag
exclud
slight
deviat
ratio
two
virus
inoculum
skew
slope
fit
data
point
plaqu
assay
perform
subconflu
monolay
day
infect
cm
dish
amount
viru
appli
plate
determin
empir
ensur
wellspac
plaqu
approxim
per
cm
dish
plate
stain
crystal
violet
hour
post
infect
plate
scan
individu
dpi
use
flatb
scanner
sixteenbit
imag
file
analyz
use
imagej
bright
contrast
circular
threshold
plaqu
identif
set
use
uninfect
plate
day
prior
infect
hela
cell
plate
plate
well
per
viru
time
point
replic
per
time
point
cell
infect
moi
volum
infect
synchron
incub
ice
hour
occasion
rock
hour
inocula
aspir
well
wash
twice
icecold
pb
ml
fresh
prewarm
growth
media
appli
well
one
set
well
immedi
frozen
hour
time
point
plate
return
incub
set
well
remov
frozen
hour
sampl
titer
growth
curv
cell
perform
use
similar
protocol
except
cell
plate
day
prior
time
point
hour
mutat
rate
measur
luriadelbruck
fluctuat
test
case
quantifi
rate
polioviru
protein
acquir
necessari
point
mutat
permit
viral
growth
mm
guanidin
hydrochlorid
fluctuat
test
perform
replic
cultur
plate
total
hela
cell
per
well
plate
day
prior
infect
case
media
chang
serumfre
media
hour
prior
infect
infect
ribavirin
serumfre
media
also
includ
drug
specifi
concentr
well
infect
volum
pfu
per
well
depend
viru
experiment
condit
five
independ
aliquot
also
save
subsequ
titer
see
ni
infect
ribavirin
infect
media
also
includ
drug
specifi
concentr
infect
cell
incub
hour
frozen
lyse
cell
media
harvest
follow
complet
cycl
transfer
microcentrifug
tube
empti
well
rins
complet
growth
media
combin
initi
lysat
lysat
clarifi
centrifug
g
minut
twentyfour
well
titer
plaqu
assay
mm
guanidin
hydrochlorid
overlay
see
five
well
titer
standard
plaqu
assay
without
guanidin
hydrochlorid
see
nf
mutat
rate
estim
data
use
nullclass
model
nfni
fraction
cultur
yield
guanidineresist
plaqu
nf
averag
number
pfu
absenc
guanidin
ni
averag
number
pfu
inoculum
describ
convert
mutat
rate
nucleotid
unit
correct
mutat
target
number
mutat
lead
score
phenotyp
number
possibl
mutat
target
site
constant
use
equat
number
distinct
mutat
could
yield
guanidineresist
phenotyp
determin
empir
isol
sequenc
entir
open
read
frame
guanidineresist
plaqu
deriv
wt
viru
guanidineresist
plaqu
deriv
wt
viru
treat
ribavirin
case
found
mutat
mediat
resist
although
total
among
plaqu
tabl
hela
cell
plate
day
prior
infect
densiti
cell
per
well
dish
day
infect
monolay
pretreat
ribavirin
serumfre
media
hour
infect
viru
moi
pfu
minut
cell
wash
pb
incub
ribavirin
addit
hour
viral
supernat
harvest
titer
tissu
cultur
infecti
dose
passag
hela
cell
plate
day
prior
infect
plate
densiti
cell
per
well
yield
cell
day
infect
infect
initi
passag
stock
either
wt
passag
perform
moi
unit
ml
media
hour
occasion
rock
hour
inoculum
aspir
cell
wash
twice
pb
ml
fresh
growth
media
appli
first
passag
wt
virus
harvest
hour
respect
passag
wt
virus
harvest
hour
respect
control
popul
infect
manner
except
virus
harvest
hour
post
infect
rselect
wt
lineag
rselect
lineag
control
wt
lineag
control
lineag
virus
titer
everi
fifth
passag
maintain
moi
approxim
hela
cell
transfect
electropor
viral
rna
transcript
ad
hela
cell
monolay
incub
day
media
passag
onto
separ
monolay
hela
cell
upon
cytopath
effect
virus
harvest
repeat
cycl
cell
debri
remov
centrifug
viral
supernat
titrat
time
frame
titer
increas
approxim
pfuml
viral
rna
isol
qiaamp
viral
rna
purif
kit
qiagen
accord
manufactur
instruct
cdna
prepar
purifi
viral
rna
rtpcr
sequenc
substitut
identifi
togeth
experi
substitut
identifi
second
mutat
introduc
bacteri
express
plasmid
use
either
overlap
extens
pcr
quickchang
sitedirect
mutagenesi
presenc
desir
mutat
absenc
addit
mutat
verifi
dna
sequenc
pv
rdrp
express
purifi
describ
previous
symsub
assay
use
measur
assembl
elong
kinet
purifi
rdrp
defin
templat
perform
describ
assay
primertempl
enzym
hela
cell
adapt
measur
use
passag
control
lineag
rselect
experi
fit
valu
wt
popul
measur
competit
assay
use
sampl
passag
cell
serial
passag
perform
follow
cell
seed
plate
densiti
cell
per
well
day
prior
infect
yield
approxim
day
infect
serial
passag
lineag
initi
passag
stock
either
wt
passag
perform
moi
ml
hour
hour
inoculum
aspir
cell
wash
twice
pb
ml
fresh
growth
media
appli
virus
harvest
hour
titer
everi
fourth
passag
ensur
moi
replic
lineag
wt
six
mice
use
experi
age
rang
distribut
male
femal
group
experi
report
tabl
day
infect
gener
health
exam
perform
anim
univers
veterinari
technic
staff
anim
assign
uniqu
ear
tag
identifi
studi
anim
hous
condit
femal
hous
togeth
group
male
litter
hous
togeth
separ
group
need
enrich
provid
anim
becam
singleh
due
fight
indic
anim
fed
rodent
chow
hindlimb
paralysi
expect
outcom
studi
moist
chow
place
floor
cage
andor
diet
gel
provid
supplement
water
provid
ad
libitum
temperatur
humid
monitor
record
daili
husbandri
staff
gener
hous
room
sheet
altern
light
dark
cycl
place
per
standard
hous
surviv
analys
mice
infect
intramuscularli
hindlimb
total
dose
mice
observ
twice
daili
lethargi
hunch
postur
scruffi
fur
paralysi
decreas
mobil
euthan
exhibit
bilater
hindlimb
paralysi
assess
perform
member
univers
veterinari
technic
staff
blind
hypothes
expect
outcom
studi
surviv
anim
euthan
day
endpoint
also
use
calcul
use
spearmankarb
method
tabl
tissu
distribut
analys
mice
infect
intraven
via
tail
vein
observ
twice
daili
mice
euthan
sever
morbid
day
conclus
experi
whole
organ
isol
mice
homogen
pb
use
bead
beater
homogen
clarifi
centrifug
g
minut
microfug
supernat
extract
chloroform
half
supernat
titer
rna
extract
remaind
use
trizol
amplifi
polioviru
genom
overlap
cdna
rtpcr
rna
harvest
either
cellfre
supernat
tissu
reversetranscrib
use
superscript
iii
first
strand
synthesi
system
rtpcr
invitrogen
mixtur
random
hexam
oligo
dt
primer
genom
fragment
amplifi
use
primer
pair
forward
base
ttaaaacagctctggggttgtacc
revers
base
gcgcacgctgaagtcattacacg
forward
base
tcgacaccatgattccctttgact
revers
base
aatttcctggtgttcctgacta
forward
base
atgcgatgttctggagatacctta
revers
base
ccgctgcaaacccgtgtga
forward
base
tttaccaacccacgcttcacctg
revers
base
ctccgaattaaagaaaaatttacccc
thermocycl
protocol
second
cycl
second
second
minut
follow
singl
cycl
minut
hold
sampl
amplif
fragment
confirm
gel
electrophoresi
equal
quantiti
pcr
product
pool
seven
hundr
fifti
nanogram
cdna
mixtur
shear
averag
size
bp
use
covari
focus
ultrason
sequenc
librari
prepar
use
nebnext
ultra
dna
librari
prep
kit
neb
agencourt
ampur
xp
bead
beckman
coulter
nebnext
multiplex
oligonucleotid
illumina
neb
final
concentr
barcod
librari
determin
quanti
picogreen
dsdna
quantif
thermofish
scientif
equal
nanomolar
concentr
pool
residu
primer
dimer
remov
gel
isol
bp
band
purifi
use
genejet
gel
extract
kit
thermofish
scientif
purifi
librari
pool
sequenc
illumina
miseq
nucleotid
pairedend
read
raw
sequenc
data
deposit
ncbi
shortread
archiv
bioproject
sequenc
read
pass
standard
illumina
qualitycontrol
filter
bin
index
align
refer
genom
use
bowti
snv
identifi
analyz
use
deepsnv
reli
clonal
control
estim
local
error
rate
within
given
sequenc
context
identifi
strand
bia
base
call
clonal
control
librari
prepar
ident
fashion
pewm
plasmid
sequenc
flow
cell
control
batch
effect
true
posit
snv
identifi
raw
output
tabl
appli
follow
filter
criteria
r
bonferonnicorrect
p
ii
averag
mapq
score
variant
read
iii
averag
phred
score
variant
posit
iv
averag
posit
variant
call
read
v
variant
frequenc
consid
snv
identifi
singl
rtpcr
reaction
sequenc
librari
sampl
copi
number
supernat
separ
rtpcr
reaction
sequenc
librari
sampl
copi
number
genom
per
eg
tissu
studi
strategi
variant
call
well
benchmark
sensit
specif
describ
code
found
http
githubcomlauringlabvariantpipelin
explicit
power
analys
use
design
experi
case
use
biolog
replic
case
use
fewer
varianc
either
suffici
low
high
number
replic
statist
test
use
relev
pvalu
report
figur
legend
main
text
fig
replic
within
dynam
rang
assay
report
ie
replic
experi
exclud
data
rel
adapt
wt
popul
analyz
linear
mixedeffect
model
estim
random
slope
intercept
time
nest
within
fit
measur
replic
measid
nest
within
lineag
replic
repid
viru
includ
fix
effect
model
fit
r
packag
code
model
found
http
githubcomlauringlabspeedfidel
